Effect of co-administration of Olmesartan and Azelnidipine on vascular endothelial function in patients with atherosclerosis-prone conditions.
Not Applicable
- Conditions
- Patients with hypertension and atherosclerosis-prone conditions.
- Registration Number
- JPRN-UMIN000004479
- Lead Sponsor
- Kitasato University School of Medicine, Cardioangiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
poor controlDM (HbA1c > 8%) or inslin usage severe liver and/or renal dysfunction moderate to severe heart failure (< 3 weeks) modelate to severe heart failure (BNP > 200 pg/mL) impossible to fix the dose oftreatments
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method